Recalls / Class II
Class IID-0216-2021
Product
PHENYLephrine HCl 5000 mg/50 mL in Sodium Chloride 0.9% (100 mcg/mL) Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004081022
- Affected lot / code info
- Lot # 1220023003, BUD 12/22/2020; 1220023057, BUD 12/25/2020; 1220023104, BUD 12/25/2020; 1220023144, BUD 12/27/2020; 1220023168, BUD 12/27/2020; 1220023222, BUD 12/29/2020; 1220023240, BUD 12/28/2020; 1220023284, BUD 1/1/2021; 1220023456, BUD 1/8/2021; 1220023474, BUD 1/4/2021; 1220023530, BUD 1/8/2021 & 1220023542, BUD 1/9/2021.
Why it was recalled
Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Recalling firm
- Firm
- SCA Pharmaceuticals
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 755 Rainbow Rd Ste B, Windsor, Connecticut 06095-1024
Distribution
- Quantity
- 3152 syringes
- Distribution pattern
- Product was distributed to hospitals nationwide.
Timeline
- Recall initiated
- 2020-12-17
- FDA classified
- 2021-01-07
- Posted by FDA
- 2021-01-13
- Terminated
- 2021-11-02
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0216-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.